Skip to main content
. 2021 Oct 20;12:699445. doi: 10.3389/fgene.2021.699445

TABLE 3.

Genotype and analyses characteristics of the 12 eligible publications.

Array type Array name QC Population stucture/PCA Imputed References Panel Final SNPs number Association Covariates/Confounding variables adjusted for Suggestive sig. Replication References
GW genotyping array Affymetrix ® GW Human SNP Array 6.0 Yes Structure = Non parametric clustering of genotypes using the AWClust algorithm; PC = using eigenstrat method No NA 8,08,465 LoRM under an additive model for HTN (PLINK V1.04); LRM for SBP and DBP (PLINK V1.04) Age, Sex, BMI, First 2 PCs of the genotypes p < 1E-4 Yes Adeyemo et al. (2009)
GW genotyping array Affymetrix GW Human SNP Array 6.0 array Yes Structure = MDS; PCs were calculated for all unrelated individuals and predicted forrelated individuals Yes Merged: YRI and CEU HapMap-phased haplotypes 2,500,000 LRM under an additive model Age, Age2, Sex, BMI, First 10 PCs p < 1E−6 Yes Fox et al. (2011)
GW genotyping array Affymetrix GeneChip SNP Array 6.0 Yes PCA Yes Merged: HapMap Phase III and the Human Genome Diversity Project ∼2,420,000 LRM/LMM for family data under additive model Age2, Sex, BMI, First 10 PCs p < 1E−5 Yes Franceschini et al. (2013)
GW genotyping array Affymetrix Axiom Biobank array designed specifically for the MVP Yes PCA using FlashPCA; Clusted by race using K-means approach K1-4 Yes 1000G phase 3, V5 NR LRM with additive models (untransformed), using SNPTEST-v2.5.4-beta Age, Age2, Sex, BMI, First 10 PCs p < 1E−6 Yes Giri et al. (2019)
GW genotyping array, GW sequencing Illumina HumanOmni 2.5M BeadChip array(UGR); Illumina HumanOmni Multi-Ethnic GWAS/Exome Array (MEGA pre-commercial v1) using the Infinium Assay a.k.a MEGA Array (DDS and DCC and some of AADM); Affymetrix Axiom GW PanAFR Array Set (AADM) Yes PCA; fineSTRUCTURE analysis (Lawson et al., 2012) Yes Merged: Uganda Genome Resource, AGVP, 1000G phase 3 >24,423,923 LMM with two random effects Age, Age2, Sex Nonea No Gurdasani et al. (2019)
GW genotyping array Affymetrix Axiom array Yes PCA; LMM using estimated kinship matrices with leave one chromosome out (LOCO) to account for population substructure and cryptic relatedness with Bolt-LMM Yes 1000G phase I >2,696,785 LMM using estimated kinship matrices in Bolt-LMM Age, Age2, Sex, BMI, First 2 ancestry PCs p ≤ 1E-2 Yes Hoffmann et al. (2017)
GW genotyping array Affymetrix GW Human SNP Array 6.0 platform Yes Family structure modeled using LME models; PCA using EIGENSTRAT Yes Merged: HapMap phase 2 CEU and YRI data ∼2,740,000 LoRM under an additive genetic model In PLINK First 10 PCs p < 1E−6 Yes Lettre et al. (2011)
GW genotyping array Either Affymetrix or Illumina Yes PCA Yes 1000G Phase 1 >30,072,738 LRM for unrelated data or by the generalized LMM for family data, under an additive genetic model Age, Age2, Sex, BMI, up to first 10 PCs p < 1E−6 Yes Liang et al. (2017)
GW genotyping array Illumina HumanOmni2.5M-8 (‘octo’) Beadchip arrays, version 1.1 (Illumina Inc., San Diego, United States) Yes Structure = LMM (GCTA V1.22) Yes Merged: 1000G, AGVP and UG2G 20,074,711 LMM regression (accounting for population substructure) (GCTA V1.22) Age, BMI p < 1E−6 Yes Lule et al. (2019)
GW genotyping array Infinium Multi‐Ethnic Global BeadChip (v1.0) Yes NA; TransMeta, follows a hierarchical framework that incorporates a kernel matrix K into the covariance structure of the effect size estimates Yes EA: HRC; AA, MA & JA: 1000G Phase 3 3,153,931 LMM using GCTA (Log & rank‐based inverse normal transformations) Age, Sex & self‐reported diabetes status (FEs) p < 1E–6 No Willems et al. (2020)
GW genotyping array MEGA array Yes PCA, (SNPRelete in R) Yes 1000G phase 3 28,263,875 LoRm and LMM, in both SUGEN and GENESIS program AHM adjustment, (for BP traits only, not HTN), First 10 PCs Noneb Yes Wojcik et al. (2019)
GW genotyping array Either with Affymetrix or the Illumina whole-genome SNP genotyping arrays Yes NA Yes NA ∼2,420,000 LRM, additive model; Plink None p < 5 × 10–7 No Zhu et al. (2015)

GWAS sig. = p < 5 × 10–8 for all studies, except for aGWAS sig. = < 5E–9) bGWAS sig. = < 3E–9 for MAF <5%.